{
  "id": 28369,
  "title": "RFK Jr.'s handpicked committee approves manufacture of peptides he uses",
  "url": "https://urgent.news/2026/07/24/rfk-jr-s-handpicked-committee-approves-manufacture-of-peptides-he-uses",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-24T19:10:09.000Z",
  "source": {
    "name": "Ars Technica Health",
    "slug": "ars-technica-health",
    "url": "https://arstechnica.com/health/2026/07/rfk-jr-s-hand-picked-committee-approves-manufacture-of-peptides-he-uses/"
  },
  "original_language": "en",
  "account": "The Food and Drug Administration (FDA) committee, handpicked by Robert F. Kennedy Jr., has voted to approve the removal of restrictions on manufacturing peptides for human use. This decision was announced during a panel meeting on Thursday, although votes on an additional three peptides are set to take place today. Despite the absence of substantial evidence regarding the safety and efficacy of these peptides, the decision was anticipated months prior. Kennedy Jr., a prominent advocate for peptides, had taken deliberate actions to ensure this outcome.\n\nPeptides, akin to proteins, are chains of amino acids, differing mainly in length - generally ranging from 10 to 20 amino acids, as opposed to proteins which can consist of hundreds or thousands. Some peptides, like insulin, are created by processing a protein into shorter fragments. These peptides interact with receptors that have evolved to send signals to cells based on their specific levels.",
  "summary": "There's no human safety or efficacy data, but that no longer seems to matter.",
  "key_points": [
    "FDA committee, handpicked by RFK Jr., approves peptide manufacturing",
    "Decision announced during Thursday panel meeting",
    "Additional three peptides to be voted on today"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}